Sonnet biotherapeutics to present preclinical data on son-080 for chemotherapy-induced peripheral neuropathy (cipn) at the aacr 2024 annual meeting
Princeton, nj / accesswire / march 19, 2024 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that preclinical data and clinical trial design from the study of son-080 (recombinant human interleukin-6 or rhil-6) in cipn will be presented in a poster session at the upcoming american association for cancer research (aacr) annual meeting 2023, to be held april 5-10, in san diego, california. presentation details: title: low dose interleukin-6 (son-080) for neuropathies: toxicology and clinical plans session title: pharmacology and pharmacogenetics presentation type: poster session date and time: wednesday april 10, 2024, 9:00 am - 12:30 pm abstract number: 7181 location: poster section 24 poster board number: 22 about sonnet biotherapeutics holdings, inc. sonnet biotherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
SONN Ratings Summary
SONN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission